NCT03262389View on ClinicalTrials.gov

Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 19, 2017

Primary Completion Date

November 23, 2019

Study Completion Date

November 23, 2019

Conditions
Multiple Myeloma
Interventions
DRUG

Fludeoxyglucose PET CT

Route of administration is intravenous. Dose of each injection will be the standard 5 to 10 millicurie (mCi).

DRUG

Sodium Acetate C11 PET CT

Route of administration is intravenous. Dose of each injection will be 10 mCi (370 MBq).

DRUG

Fludeoxyglucose PET MRI

Route of administration is intravenous. Dose of each injection will be the standard 5 to 10 millicurie (mCi).

DRUG

Sodium Acetate C11 PET MRI

Route of administration is intravenous. Dose of each injection will be 10 mCi (370 MBq).

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

All Listed Sponsors
lead

Michael C Roarke, MD

OTHER

NCT03262389 - Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma | Biotech Hunter | Biotech Hunter